Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization – News-Medical.Net

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization – News-Medical.Net

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two mo… [read more]

Leave a Reply

Your email address will not be published.